ETF Managers Group’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$298K Buy
163,948
+64,147
+64% +$199K 0.01% 538
2022
Q4
$506K Sell
99,801
-18,326
-16% -$101K 0.02% 364
2022
Q3
$587K Sell
118,127
-7,601
-6% -$34.6K 0.02% 349
2022
Q2
$474K Buy
125,728
+5,063
+4% +$20.3K 0.01% 511
2022
Q1
$711K Buy
120,665
+492
+0.4% +$3.02K 0.01% 385
2021
Q4
$767K Sell
120,173
-22,652
-16% -$170K 0.02% 387
2021
Q3
$1.37M Buy
142,825
+24,670
+21% +$271K 0.03% 237
2021
Q2
$1.72M Buy
118,155
+80,521
+214% +$1.33M 0.03% 237
2021
Q1
$894K Sell
37,634
-15,185
-29% -$394K 0.02% 290
2020
Q4
$758K Sell
52,819
-7,723
-13% -$74.3K 0.02% 269
2020
Q3
$435K Buy
60,542
+32,807
+118% +$327K 0.01% 335
2020
Q2
$300K Buy
+27,735
New +$157K 0.01% 413

Other funds holding IBRX